XPH vs. EDOC
XPH (SPDR S&P Pharmaceuticals ETF) and EDOC (Global X Telemedicine & Digital Health ETF) are both Health & Biotech Equities funds - XPH tracks the S&P Pharmaceuticals Select Industry Index while EDOC tracks the Solactive Telemedicine & Digital Health Index- TR Net. Both are passively managed. Over the past 5 years, XPH returned 7.00%/yr vs -12.35%/yr for EDOC. A 0.62 correlation means they provide meaningful diversification when combined. XPH charges 0.35%/yr vs 0.68%/yr for EDOC.
Performance
XPH vs. EDOC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 19.55% return, which is significantly higher than EDOC's -2.48% return.
XPH
- 1D
- -2.37%
- 1M
- 10.98%
- 6M
- 20.41%
- YTD
- 19.55%
- 1Y
- 59.80%
- 3Y*
- 18.81%
- 5Y*
- 7.00%
- 10Y*
- 5.22%
EDOC
- 1D
- 0.90%
- 1M
- 10.17%
- 6M
- -8.11%
- YTD
- -2.48%
- 1Y
- -7.84%
- 3Y*
- -7.38%
- 5Y*
- -12.35%
- 10Y*
- —
XPH vs. EDOC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 19.55% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 20.61% |
EDOC Global X Telemedicine & Digital Health ETF | -2.48% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 16.89% |
Correlation
The correlation between XPH and EDOC is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2020 | 0.62 |
The correlation between XPH and EDOC has been stable across timeframes, ranging from 0.53 to 0.62 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. EDOC — Risk / Return Rank
XPH
EDOC
XPH vs. EDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Global X Telemedicine & Digital Health ETF (EDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XPH | EDOC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.03 | ||
| Sortino ratioReturn per unit of downside risk | +3.92 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 0.96 | +0.47 |
| Calmar ratioReturn relative to maximum drawdown | 5.02 | -0.26 | +5.28 |
| Martin ratioReturn relative to average drawdown | 17.95 | -0.48 | +18.43 |
Loading charts...
Drawdowns
XPH vs. EDOC - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, smaller than the maximum EDOC drawdown of -65.76%. Use the drawdown chart below to compare losses from any high point for XPH and EDOC.
Loading charts...
Drawdown Indicators
| XPH | EDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -65.76% | +17.73% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -30.71% | +18.74% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -35.78% | +12.21% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -59.14% | +27.51% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | — | — |
Current DrawdownCurrent decline from peak | -4.61% | -57.90% | +53.29% |
Average DrawdownAverage peak-to-trough decline | -17.17% | -43.33% | +26.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.34% | 16.31% | -12.97% |
Volatility
XPH vs. EDOC - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) and Global X Telemedicine & Digital Health ETF (EDOC) have volatilities of 7.24% and 7.18%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | EDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 7.18% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 17.37% | 17.10% | +0.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.49% | 22.68% | -0.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.10% | 26.59% | -5.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.10% | 26.29% | -4.19% |
XPH vs. EDOC - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than EDOC's 0.68% expense ratio.
Dividends
XPH vs. EDOC - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.50%, more than EDOC's 0.25% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.25% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.50% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and EDOC have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.24%) compared to EDOC (7.18%). In terms of maximum drawdown, XPH dropped -48.03% vs EDOC's -65.76%.
On 5-year performance, XPH leads with 7.00% vs -12.35% for EDOC. On fees, XPH is cheaper at 0.35% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, XPH has performed better with a 7.00% return vs -12.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.68% for EDOC.
XPH has the higher dividend yield at 0.50%, compared with 0.25% for EDOC.
XPH tracks S&P Pharmaceuticals Select Industry Index, while EDOC tracks Solactive Telemedicine & Digital Health Index- TR Net. They also come from different issuers: State Street and Global X. Their fees differ too: 0.35% for XPH and 0.68% for EDOC.
XPH currently has the higher Sharpe Ratio (2.68 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and EDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer